New Hampshire Senate Bill 465
Session 2026
Classifying xylazine as a schedule III controlled drug.
Active
Failed in House on Apr 23, 2026
Origin Chamber
Senate
Type
Bill
Bill Number
465
State
New Hampshire
Session
2026
Jennifer M Rhodes
Cosponsor
Terry W Roy
Cosponsor
Senate votes are unavailable for this bill.
Summary
Unavailable
As Amended by the Senate
Sort by most recent
04/23/2026
House
Inexpedient to Legislate: MA VV 04/23/2026 HJ 11
04/15/2026
House
Minority Committee Report: Ought to Pass
04/15/2026
House
Majority Committee Report: Inexpedient to Legislate 04/14/2026 (Vote 11-5; RC)
04/08/2026
House
Executive Session: 04/14/2026 01:00 pm GP 153
04/01/2026
House
Full Committee Work Session: 04/07/2026 01:00 pm GP 153
03/18/2026
House
Public Hearing: 03/31/2026 01:30 pm GP 153
03/16/2026
House
Introduced (in recess of) 03/12/2026 and referred to Environment and Agriculture HJ 8
02/24/2026
Senate
Ought to Pass with Amendment #2026-0842s, MA, VV; OT3rdg; 03/05/2026; SJ 5
02/24/2026
Senate
Committee Amendment # 2026-0842s, AA, VV; 03/05/2026; SJ 5
02/20/2026
Senate
Committee Report: Ought to Pass with Amendment # 2026-0842s, 03/05/2026; Vote 5-0; CC; SC 8
02/05/2026
Senate
Hearing: 02/10/2026, Room 100, SH, 01:30 pm; SC 5A
11/21/2025
Senate
Introduced 01/07/2026 and Referred to Judiciary; SJ 1
Sources
Open States
Record Created
Dec 9, 2025 9:06:47 PM
Record Updated
May 7, 2026 5:00:15 PM